Skip to content
  • About us
    • About us
    • Executive commitee
    • Board of Directors
    • Scientific advisors
    • Corporate governance
    • ESG
  • myvac
    • myvac – individualized therapeutic vaccines
  • Pipeline
    • Pipeline
    • TG4050
    • TG4070
    • BT-001
    • TG6050
    • Publications and Presentations
    • Clinical trials FAQ
  • Investors
    • Investor Presentation & Contacts
    • Press releases & events
    • Financial Information
    • Stock Information
    • Annual General Meeting
  • Career
  • English
  • French
PHP Toggle Menu

Category: Press release

Transgene’s Combined General Meeting of May 15, 2025

Combined general meeting 2025

Published 15 May 2025
Categorized as 2025, Press release

Transgene Provides Business and Financial Update for Q1 2025

Q1 financial 2025

Published 24 April 2025
Categorized as 2025, Press release

Availability of Preparatory Documents for the Combined General Meeting of May 15, 2025

AG 2025

Published 24 April 2025
Categorized as 2025, Press release

Transgene to Provide Updated Phase I Data in a Rapid Oral Presentation on Individualized Therapeutic Cancer Vaccine TG4050 at ASCO 2025

ASCO 2025 curtain

Published 23 April 2025
Categorized as 2025, Myvac, Press release, TG4050

Availability of Transgene’s 2024 Universal Registration Document (URD)

URD 2024

Published 10 April 2025
Categorized as 2025, Press release

Transgene Appoints Chief Technical Officer (CTO) to Power Future Innovations

CTO Appointment

Published 1 April 2025
Categorized as 2025, Press release

Transgene Achieves Key Milestones in 2024, Including Clinical Proof of Principle for Individualized Cancer Vaccine – Strong Outlook for 2025

2024 Annual Results

Published 27 March 2025
Categorized as 2025, Press release

Transgene to Participate in Upcoming Investor Meetings

Investors meetings

Published 11 March 2025
Categorized as 2025, Press release

Transgene Shares (Euronext Paris: TNG) Eligible for Inclusion in PEA-PME Accounts

Eligibility PEA-PME

Published 6 February 2025
Categorized as 2025, Press release, TG6050-en

Transgene To Participate in the Biomed Forum Investor Conference

BIOMED FORUM

Published 21 January 2025
Categorized as 2025, dates, dates, Press release, TG6050-en, TG6050-en

Posts pagination

Newer posts Page 1 … Page 5 … Page 33 Older posts
Get to know us

About us

myvac

Pipeline

Investors

Partnering

Company

Career

ESG

Suppliers

Contacts

Legal documents

Legal notices

Privacy Policy

Ethics and compliance

Cookie policy

  • About us
    • About us
    • Executive commitee
    • Board of Directors
    • Scientific advisors
    • Corporate governance
    • ESG
  • myvac
    • myvac – individualized therapeutic vaccines
  • Pipeline
    • Pipeline
    • TG4050
    • TG4070
    • BT-001
    • TG6050
    • Publications and Presentations
    • Clinical trials FAQ
  • Investors
    • Investor Presentation & Contacts
    • Press releases & events
    • Financial Information
    • Stock Information
    • Annual General Meeting
  • Career
  • English
  • French
Menu